Clostridium difficile infection among children across diverse us geographic locations

Pediatrics

Volumn 133, Issue 4, 2014, Pages 651-658

  Wendt, Joyanna M ^a,b   Cohen, Jessica A ^a,c   Mu, Yi ^a   Dumyati, Ghinwa K ^d   Dunn, John R ^e   Holzbauer, Stacy M ^b,f   Winston, Lisa G ^g   Johnston, Helen L ^h   Meek, James I ⁱ   Farley, Monica M ^j,k   Wilson, Lucy E ^l   Phipps, Erin C ^m   Beldavs, Zintars G ⁿ   Gerding, Dale N ^o,p   McDonald, Clifford ^a   Gould, Carolyn V ^a   Lessa, Fernanda C ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e TENNESSEE DEPARTMENT OF HEALTH   (United States)

^f MINNESOTA DEPARTMENT OF HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h University of California San Francisco School of Medicine ^*  (United States)

ⁱ YALE UNIVERSITY   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ATLANTA VA MEDICAL CENTER   (United States)

^l MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^m UNIVERSITY OF NEW MEXICO   (United States)

ⁿ OREGON HEALTH AUTHORITY   (United States)

^o LOYOLA UNIVERSITY CHICAGO   (United States)

^p HINES VA HOSPITAL   (United States)

more..

Author keywords

Antimicrobial stewardship; Clostridium difficile; Community associated; Pediatric

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; FECES ANALYSIS; FEMALE; GEOGRAPHIC ORIGIN; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENICITY; PRIORITY JOURNAL; PROTOZOAL INFECTION; UNITED STATES; VIRUS INFECTION;

ANTIMICROBIAL STEWARDSHIP; CLOSTRIDIUM DIFFICILE; COMMUNITY-ASSOCIATED; PEDIATRIC;

CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; UNITED STATES;

EID: 84898721140     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3049     Document Type: Article

References (34)

1. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005; 353(23):2433-2441
2. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics. 2008;122(6):1266-1270
3. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis. 2010;16(4):604-609
4. Tullus K, Aronsson B, Marcus S, Mollby R. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis. 1989;8(5):390-393
5. Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis. 2012;55(9):1209-1215
6. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010;51(1):2-7
7. Eglow R, Pothoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest. 1992;90(3):822-829
8. Schutze GE, Willoughby RE; American Academy of Pediatrics Committee on Infectious Diseases. Clostridium difficile infection in infants and children. Pediatrics. 2013;131(1):196-200
9. Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk -four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54(47):1201-1205
10. United States Census Bureau. Available at http://www.census.gov/. Accessed May 15, 2013
11. Centers for Disease Control and Prevention. Measuring the scope of Clostridium difficile infection in the United States. Available at: www.cdc.gov/hai/eip/clostridium-difficile.html. Accessed May 15, 2013
12. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455
13. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742-748
14. Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandemrepeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008;46(2):431-437
15. Pant C, Anderson MP, Deshpande A, et al. Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(5):1080-1085
16. Hicks LA, Taylor TH Jr., Hunkler RJUS. U.S. outpatient antibiotic prescribing, 2010. N Engl J Med. 2013;368(15):1461-1462
17. Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16(2):197-204
18. Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13. 2006(159):1-66
19. Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficileassociated disease in children. Infect Control Hosp Epidemiol. 2007;28(11):1233-1235
20. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J. 2011;30(7):580-584
21. Pépin J, Gonzales M, Valiquette L. Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. J Infect. 2012;64(4):387-390
22. Matsuki S, Ozaki E, Shozu M, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol. 2005;8(1):43-48
23. Harvey RB, Norman KN, Andrews K, et al. Clostridium difficile in retail meat and processing plants in Texas. J Vet Diagn Investig. 2011;23(4):807-811
24. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15(5):819-821
25. Weese JS. Clostridium difficile in food -innocent bystander or serious threat? Clin Microbiol Infect. 2010;16(1):3-10
26. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173(14):1359-1367
27. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23): 3096-3102
28. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1451-1465
29. Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157-162
30. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243-245
31. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and casecontrol studies. CMAJ. 2004;171(1):33-38
32. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294 :2989-2995
33. Valentini D, Vittucci AC, Grandin A, et al. Coinfection in acute gastroenteritis predicts a more severe clinical course in children. Eur J Clin Microbiol Infect Dis. 2013;32(7):909-915
34. Owens RC Jr., Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41(suppl 2):S144-S157